The document is the preliminary final report for XRF Scientific Limited for the financial year ended 30 June 2022. It provides a comprehensive overview of the company's financial performance, including key financial data such as revenue, profits, dividends, basic and diluted earnings per share, and net tangible assets per security. The report highlights significant revenue growth, increased profitability, and the declaration of a final dividend. It discusses the company's principal activities in manufacturing and marketing precious metal products, chemicals, and analytical instruments, as well as the strategic outlook and business risks. Detailed financial statements, segment reporting, and notes to the accounts are included, along with commentary on operations, significant events, and the impact of external factors on the company's results.
Key Points
XRF Scientific Limited reported strong revenue growth and increased profitability for the year ended 30 June 2022.
Net profit after tax was $8,954,352, up from $5,624,764 in the prior year.
Basic earnings per share increased to 5.45 cents from 3.57 cents the previous year.
A fully franked final dividend of 3.6 cents per share was declared.
The company operates in the manufacturing and marketing of precious metal products, chemicals, and analytical instruments.
Segment reporting identifies divisions including Precious Metals, Chemicals, and Capital Equipment.
The Group expanded its operations, invested in new equipment, and pursued international market opportunities.
The company highlighted business risks such as supply chain disruptions and economic uncertainties.
No matters or circumstances have arisen since the end of the financial year that have significantly affected operations.
The report includes detailed financial statements and accompanying notes explaining accounting policies and financial results.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.